Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Enterprise Value: 2020-2025

Historic Enterprise Value for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to $4.4 million.

  • iSpecimen's Enterprise Value rose 229.05% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 113.27%. This contributed to the annual value of $677,393 for FY2024, which is 246.54% up from last year.
  • Per iSpecimen's latest filing, its Enterprise Value stood at $4.4 million for Q3 2025, which was up 134.80% from $1.9 million recorded in Q2 2025.
  • iSpecimen's 5-year Enterprise Value high stood at $40.4 million for Q4 2021, and its period low was -$6.0 million during Q3 2022.
  • Over the past 3 years, iSpecimen's median Enterprise Value value was $932,256 (recorded in 2024), while the average stood at $1.3 million.
  • Per our database at Business Quant, iSpecimen's Enterprise Value spiked by 5,910.92% in 2021 and then plummeted by 142.27% in 2024.
  • Over the past 5 years, iSpecimen's Enterprise Value (Quarterly) stood at $40.4 million in 2021, then slumped by 108.07% to -$3.3 million in 2022, then soared by 85.83% to -$462,253 in 2023, then spiked by 246.54% to $677,393 in 2024, then surged by 229.05% to $4.4 million in 2025.
  • Its last three reported values are $4.4 million in Q3 2025, $1.9 million for Q2 2025, and $237,832 during Q1 2025.